Get complete access to comprehensive company data for Haus Bioceuticals India Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Haus Bioceuticals India Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 1.00 lakh
₹ 0.97 lakh
16 Sep 2016
31 Mar 2023
Haus Bioceuticals India Private Limited is an Indian private limited company incorporated on 16 Sep 2016. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Haus Bioceuticals India Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2023 (FY 2022-2023).
Haus Bioceuticals India Private Limited is a company limited by shares with an authorized capital of ₹1.00 lakh and a paid-up capital of ₹0.97 lakh as per the records maintained by the Ministry of Corporate Affairs (MCA).
Haus Bioceuticals India Private Limited has 3 directors. The directors of the company include Tomy Yesudas, Michael Benjamin Centola, Philip Jacob Alex.
The registered office of Haus Bioceuticals India Private Limited is located at No 677 First Floor Suite No 761 27Th Main 13Th Cross Hsr Layout Sector 1 Bangalore Karnataka 560102 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U74999KA2016FTC096511
- Legal Name: Haus Bioceuticals India Private Limited
- ROC Code: Roc Bangalore
- Company No.: 096511
- Company Category: Company Limited By Shares
- Company Sub Category: Subsidiary Of Company Incorporated Outside India
- Company Class: Private
- Listing Status: Unlisted
- Industry: Other Business Activities
- Date of AGM: 31 Oct 2023
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Haus Bioceuticals India Private Limited |
|---|
Frequently Asked Questions
- michael benjamin centola
- philip jacob alex
- tomy yesudas